简介：
Overview
This study presents a protocol for differentiating, expanding, and cryopreserving brain microvascular endothelial cells (BMECs) from human induced pluripotent stem cells (iPSCs). It focuses on investigating blood-brain barrier properties using an ex vivo model.
Key Study Components
Area of Science
- Neuroscience
- Stem Cell Biology
- Vascular Biology
Background
- BMECs play a crucial role in maintaining blood-brain barrier integrity.
- Disruptions in the blood-brain barrier are implicated in various neurological disorders.
- Human iPSCs provide a model for personalized medicine approaches.
- The protocol allows the generation of disease-specific BMECs.
Purpose of Study
- To optimize the differentiation protocol for BMECs derived from iPSCs.
- To evaluate the effects of expansion and cryopreservation on barrier properties.
- To investigate the applicability of these BMECs in studying blood-brain barrier function.
Methods Used
- The method relies on differentiation of human iPSCs into BMECs via a stepwise cell culture protocol.
- Key steps include culturing in specific media, the use of ROCK inhibitors, and transwell assays for barrier property assessment.
- TEER measurements and efflux transporter assays are used for functional analysis.
- Cell morphology and differentiation efficiency are monitored over eight days.
Main Results
- BME cells maintained tight junction properties and appropriate morphology post-differentiation.
- TEER values indicated functional integrity; however, cryopreservation reduced these properties.
- Efflux transporter activity was demonstrated, suggesting preserved functionality.
- The methodology allows for the modeling of blood-brain barrier mechanisms in health and disease.
Conclusions
- This protocol enables the generation of patient-derived BMECs for studying blood-brain barrier function.
- It provides insights into the effects of cryopreservation on barrier properties.
- The study has implications for developing therapeutic strategies targeting the blood-brain barrier.
What are the advantages of using iPSC-derived BMECs?
iPSC-derived BMECs offer a patient-specific model that accurately represents individual blood-brain barrier conditions and dysfunctions.
How is the differentiation of iPSCs into BMECs achieved?
The differentiation involves culturing iPSCs in enzymatic EDTA, followed by exposure to a specific growth factor medium and coatings to promote endothelial characteristics.
What types of data are obtained from this model?
Functional data such as TEER measurements and efflux transporter activity, alongside morphological assessments and expression of tight junction proteins, are obtained.
How can this method be adapted for different research needs?
The protocol can be customized to model specific diseases by utilizing patient-derived iPSCs and modifying growth conditions to reflect disease mechanisms.
What are the limitations of the model?
Variability in differentiation efficiency and the impact of cryopreservation on cell functionality may affect reproducibility and experimental outcomes.
繁體中文
